Esophageal Cancer: The Latest On Chemoprevention And State Of The Art Therapies

Keywords

Cancer prevention; Chemotherapy; Esophageal cancer; Immunotherapy; Treatment

Abstract

Esophageal cancer is currently the 8th most common cancer worldwide and the 6th leading cause of cancer-related mortality. Despite remarkable advances, the mortality for those suffering from esophageal cancer remains high, with 5-year survival rates of less than 20%. In part, because most patients present with late-stage disease, long-term survival even after resection and therapy is disappointingly low. As we will discuss in this review, multiple characteristics specific to the disease stage and patient must be considered when choosing a treatment plan. This article will summarize current standard therapies, potential application of chemoprevention drugs and the promise and partial failure of personalized medicine, as well as novel treatments addressing this disease.

Publication Date

11-1-2016

Publication Title

Pharmacological Research

Volume

113

Number of Pages

236-244

Document Type

Editorial Material

Personal Identifier

scopus

DOI Link

https://doi.org/10.1016/j.phrs.2016.08.021

Socpus ID

84985930340 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/84985930340

This document is currently not available here.

Share

COinS